Growth Metrics

Health Catalyst (HCAT) Debt to Equity (2018 - 2026)

Health Catalyst filings provide 9 years of Debt to Equity readings, the most recent being $1.11 for Q1 2026.

  • On a quarterly basis, Debt to Equity rose 9.27% to $1.11 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.11, a 9.27% increase, with the full-year FY2025 number at $0.62, down 40.44% from a year prior.
  • Debt to Equity hit $1.11 in Q1 2026 for Health Catalyst, up from $0.62 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.11 in Q1 2026 to a low of $0.0 in Q2 2024.
  • Median Debt to Equity over the past 5 years was $0.58 (2023), compared with a mean of $0.63.
  • Biggest five-year swings in Debt to Equity: tumbled 99.57% in 2024 and later surged 17482.9% in 2025.
  • Health Catalyst's Debt to Equity stood at $0.53 in 2022, then rose by 16.6% to $0.62 in 2023, then surged by 68.46% to $1.05 in 2024, then crashed by 40.44% to $0.62 in 2025, then soared by 78.05% to $1.11 in 2026.
  • The last three reported values for Debt to Equity were $1.11 (Q1 2026), $0.62 (Q4 2025), and $0.46 (Q3 2025) per Business Quant data.